World AIDS Day - 1 December 2006
- Financial Times "Business and AIDS" survey
- Tata Group receives UNAIDS award
- Cipla, Ranbaxy to cut paediatric antiretroviral drug prices to $60/year for poor countries in deal with Clinton Foundation
- ILO report: HIV/AIDS costing more than 1 million new jobs/year; says workplace should be major entry point for prevention & access to treatment
- Drug firms failed to reach new agreement on wide access to HIV/AIDS medicines in poor countries, says union head
Financial Times "Business and AIDS" survey
- A new mood of cooperation [re: pharmaceutical companies], Andrew Jack (refers to Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, Roche)
- In need of a new source of funds, Andrew Jack (refers to American Express, Armani, BroadReach Healthcare, Gap, Motorola)
- An ever wider gap, Andrew Jack (refers to L'Oreal)
- Technology to the fore, Andrew Jack (refers to Anglo American, De Beers)
- The risk of epidemic dawns [China], Angelica Wiederhecker (refers to Bayer, Lafarge, Merck, Standard Chartered)
- India: A threat to economic ambition, Jo Johnson
- A problem with patriarchal society [Russia], Isabel Gorst (refers to Sual, Wimm Bill Dann)
- A partnership for Health [So. Africa], Richard Branson, Chairman of Virgin Group and Mark Dybul, ambassador for US Global Aids Coordinator (refers to Anglo American, Virgin Group)
Cipla, Ranbaxy to cut paediatric antiretroviral drug prices to $60/year for poor countries in deal with Clinton Foundation
- Cipla, Ranbaxy To Cut Pediatric Antiretroviral Drug Prices Ahead of World AIDS Day Under Deal With Clinton Foundation, Kaiser Network Daily Reports [USA]
- Clinton Foundation press release: President Clinton Announces Breakthroughs in HIV/AIDS Treatment for Children -- 3-in-1 Pill for less than $60 Annually and 45% Price Reductions for other Pediatric Drugs
ILO report: HIV/AIDS costing more than 1 million new jobs/year; says workplace should be major entry point for prevention & access to treatment
Drug firms failed to reach new agreement on wide access to HIV/AIDS medicines in poor countries, says union head
Pharmaceutical Industry Fails in Developing Industry-Wide HIV/AIDS Initiative, International Federation of Chemical, Energy, Mine and General Workers' Unions